Literature DB >> 28274997

What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver.

Philip M Brown1, Yaron Rotman1.   

Abstract

Entities:  

Keywords:  FATTY LIVER; LIVER REGENERATION; NONALCOHOLIC STEATOHEPATITIS

Mesh：

Year:  2017        PMID： 28274997      PMCID： PMC6280668          DOI： 10.1136/gutjnl-2017-313712

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

Review 2.  Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease.

Authors:  Daniel Jahn; Monika Rau; Heike M Hermanns; Andreas Geier
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-28       Impact factor: 7.638

3.  Prometheus' little helper, a novel role for fibroblast growth factor 15 in compensatory liver growth.

Authors:  Frank G Schaap; Isabelle A Leclercq; Peter L M Jansen; Steven W Olde Damink
Journal:  J Hepatol       Date:  2013-07-16       Impact factor: 25.083

4.  Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.

Authors:  Iker Uriarte; Maite G Fernandez-Barrena; Maria J Monte; Maria U Latasa; Haisul C Y Chang; Simone Carotti; Umberto Vespasiani-Gentilucci; Sergio Morini; Eva Vicente; Axel R Concepcion; Juan F Medina; José Juan G Marin; Carmen Berasain; Jesus Prieto; Matías A Avila
Journal:  Gut       Date:  2013-01-03       Impact factor: 23.059

5.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Authors:  Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison
Journal:  Gastroenterology       Date:  2010-09-19       Impact factor: 22.682

Review 6.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

7.  The impact of hepatic steatosis on liver regeneration after partial hepatectomy.

Authors:  Petra G Kele; Eric J van der Jagt; Annette S H Gouw; Ton Lisman; Robert J Porte; Marieke T de Boer
Journal:  Liver Int       Date:  2013-01-14       Impact factor: 5.828

8.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Volumetric gain of the liver after major hepatectomy in obese patients: a case-matched study in 84 patients.

Authors:  Stéphanie Truant; Ahmed Fouad Bouras; Gheorghe Petrovai; David Buob; Olivier Ernst; Emmanuel Boleslawski; Mohamed Hebbar; François-René Pruvot
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

10.  Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.

Authors:  Yan Li; Weizhong Zhang; Anne Doughtie; Guozhen Cui; Xuanyi Li; Harshul Pandit; Yingbin Yang; Suping Li; Robert Martin
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.